xpoviopro.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title Healthcare Professional Site | XPOVIO®
Description The first and only FDA‑approved XPO1 inhibitor that helps restore the body’s own tumor suppressor XPOVIO treats adult patients with multiple myeloma who have received at least 1 prior therapy or with relapsed/refractory disease. See Full Safety
Keywords N/A
Server Information
WebSite xpoviopro faviconxpoviopro.com
Host IP 38.87.43.142
Location United States
Related Websites
Site Rank
More to Explore
xpoviopro.com Valuation
US$10,916,526
Last updated: 2023-05-08 17:47:01

xpoviopro.com has Semrush global rank of 969,567. xpoviopro.com has an estimated worth of US$ 10,916,526, based on its estimated Ads revenue. xpoviopro.com receives approximately 1,259,600 unique visitors each day. Its web server is located in United States, with IP address 38.87.43.142. According to SiteAdvisor, xpoviopro.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$10,916,526
Daily Ads Revenue US$10,077
Monthly Ads Revenue US$302,304
Yearly Ads Revenue US$3,627,646
Daily Unique Visitors 83,974
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
xpoviopro.com. A 3599 IP: 38.87.43.142
xpoviopro.com. NS 3600 NS Record: ns43.domaincontrol.com.
xpoviopro.com. NS 3600 NS Record: ns44.domaincontrol.com.
xpoviopro.com. TXT 3600 TXT Record: google-site-verification=OPzF1n9QHTjDQxrwgQiFqbr_xqPkpoJ839NHLUPMkxU
HtmlToTextCheckTime:2023-05-08 17:47:01
This site is intended for US healthcare professionals only. Important Safety Information Prescribing Information Patient Website Indications Multiple Myeloma (MM) Relapsed or Refractory Diffuse Large B-Cell Lymphoma (RR DLBCL) Multiple Myeloma MM Relapsed or Refractory Diffuse Large B-Cell Lymphoma RR DLBCL The first and only FDA‑approved XPO1 inhibitor that helps restore the body’s own tumor suppressor pathways. 1-3 The X Factor Restore Your Patients Own Cancer Defenses Restore your patients’ own cancer defenses In MM or RR DLBCL, INDICATIONS XPOVIO ® (selinexor) is a prescription medicine approved: in combination with bortezomib and dexamethasone (XVd) to treat adult patients with multiple myeloma (MM) who have received at least one prior therapy. IMPORTANT SAFETY INFORMATION Thrombocytopenia: XPOVIO can cause life-threatening thrombocytopenia, potentially leading to hemorrhage. Thrombocytopenia was reported in patients with multiple myeloma (MM) and developed or worsened in
HTTP Headers
HTTP/1.1 200 OK
Cache-Control: private,max-age=600
Content-Length: 47328
Content-Type: text/html
Last-Modified: Tue, 05 Oct 2021 17:08:19 GMT
Accept-Ranges: bytes
ETag: "80823798bbad71:0"
Server: Microsoft-IIS/10.0
X-Powered-By: ASP.NET
Content-Security-Policy: default-src 'self' https: data: 'unsafe-inline' 'unsafe-eval'
Referrer-Policy: no-referrer-when-downgrade
Strict-Transport-Security: max-age=31536000; includeSubdomains
X-Content-Type-Options: nosniff
X-Frame-Options: SAMEORIGIN
X-Xss-Protection: 1; mode=block
Date: Sat, 30 Oct 2021 11:19:30 GMT
xpoviopro.com Whois Information
Domain Name: XPOVIOPRO.COM
Registry Domain ID: 2449216298_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2019-10-29T17:28:42Z
Creation Date: 2019-10-29T17:28:41Z
Registry Expiry Date: 2021-10-29T17:28:41Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS43.DOMAINCONTROL.COM
Name Server: NS44.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-17T21:41:00Z <<<